# FDA recall D-0857-2018

> **Teva Pharmaceuticals USA** · Class III · drug recall initiated 2018-04-30.

## Product

Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30)

## Reason for recall

Failed Stability Specifications

## Distribution

United States

## Key facts

- **Recall number:** D-0857-2018
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-04-30
- **Report date:** 2018-05-30
- **Termination date:** 2019-01-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Wales, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0857-2018

## Citation

> AI Analytics. FDA recall D-0857-2018. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-0857-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*